TYMS and cancer: The gold complexes 7 and 8 herein studied, by targeting hDHFR, in addition to TrxR, can represent alternative drugs to be used in combined therapies, able to resolve the accumulation of dihydrofolate resulting from the TS overexpression in resistant cancer cells.